|Bid||0.00 x 1800|
|Ask||0.00 x 800|
|Day's Range||55.36 - 55.98|
|52 Week Range||42.17 - 73.23|
|Beta (3Y Monthly)||1.49|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 6, 2019 - Feb 11, 2019|
|Forward Dividend & Yield||1.91 (3.43%)|
|1y Target Est||55.07|
In this era of increased stock market volatility, a dividend focused approach can give peace of mind and likely a better chance at above average returns, suggests income expert Tim Plaehn, editor of The Dividend Hunter.
Cardinal Health Inc NYSE:CAHView full report here! Summary * Perception of the company's creditworthiness is negative but improving * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is extremely low for CAH with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting CAH. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding CAH totaled $16.45 billion. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Consumer Services sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swap | NegativeThe current level displays a negative indicator with a strengthening bias over the past 1-month. CAH credit default swap spreads are near their highest levels for the past 1 year, which indicates the market's more negative perception of the company's credit worthiness.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
shares rose after the company beat second-quarter earnings and revenue expectations. "We are making good progress on our strategic initiatives to drive future growth and are well-positioned to exceed our cost-savings targets for the enterprise.
Cardinal Health Inc. is meeting goals to cut expenses and turn around a struggling medical device acquisition in a year with rising sales but narrower margins.
Investing.com -- Hanesbrands , Sealed Air and Cardinal rallied into the close Thursday shrugging off the slump in the broader market.
Dunkin' Brands DNKN – Shares of the restaurant operator dropped nearly 5 percent after the company reported revenue that missed estimates. For quarterly earnings, Dunkin' Brands beat estimates by three cents. Chipotle Mexican Grill CMG – Chipotle stock surged a whooping 14 percent after the restaurant chain reported adjusted quarterly profit of $1.72 per share, beating the consensus estimate of $1.37.
Cardinal Health's (CAH) Q2 results benefit from strong sales in the Pharmaceutical segment. An upbeat guidance is indicative of brighter prospects.
Cardinal (CAH) delivered earnings and revenue surprises of 18.35% and 4.10%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
The Dublin, Ohio-based company said it had profit of 93 cents per share. Earnings, adjusted for one-time gains and costs, came to $1.29 per share. The results surpassed Wall Street expectations. The average ...
-- Revenue increased 7 percent to $37.7 billion -- GAAP(1) operating earnings increased 26 percent to $504 million , and non-GAAP operating earnings decreased 13 percent to $637 million -- GAAP diluted ...
A Chicago dermatology drug company that made headlines in 2016 for hiking up its drug prices has filed for bankruptcy protection. Novum Pharma filed for bankruptcy protection on Sunday, claiming assets of $19.4 million and liabilities of $53.1 million. The 5-year-old company's liabilities consist of $35 million in current liabilities and $18 million in long-term liabilities.
Cardinal Health (CAH) likely to gain from solid Pharmaceutical revenues in fiscal Q2; medical-gloves sub-segment likely to be soft.
Of these deaths, 47,600 (67.8%) involved opioids and 17,000 involved prescription opioids (24% of total overdose deaths). According to the National Institute on Drug Abuse, in the late 1990s, pharmaceutical companies reassured the medical community that patients would not become addicted to prescription opioid pain relievers, and healthcare providers began to prescribe them at greater rates. Today pharma distributors are used as scapegoats for the opioid epidemic — not because they are guilty but because they have money and they are “drug distributors.” They are dragged through the same mud as were the tobacco companies and British Petroleum (after it spilled millions of gallons of oil into the Gulf of Mexico).
The Dividend Aristocrats are a group of 57 high quality businesses with the following characteristics: they have increased their dividend for 25+ consecutive years, they meet certain minimum size and liquidity requirements and they are in the S&P; 500, explains Ben Reynolds, CEO and editor of Sure Dividend.
Cardinal (CAH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Myriad (MYGN) likely to deliver solid Q2 results on the diversified Molecular Diagnostics portfolio with products like GeneSight, EndoPredict, BRACAnalysis CDx and Prolaris tests.
This article is written for those who want to get better at using price to earnings ratios (P/E ratios). We'll look at Cardinal Health, Inc.'s (NYSE:CAH) P/E ratio and reflect Read More...
Today we are going to look at Cardinal Health, Inc. (NYSE:CAH) to see whether it might be an attractive investment prospect. To be precise, we'll consider its Return On Capital Read More...